Sean Rahilly - Feb 16, 2024 Form 4 Insider Report for Enova International, Inc. (ENVA)

Signature
/s/ Sean Rahilly
Stock symbol
ENVA
Transactions as of
Feb 16, 2024
Transactions value $
-$692,000
Form type
4
Date filed
2/21/2024, 07:38 PM
Previous filing
Feb 12, 2024
Next filing
May 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENVA Common Stock, par value $0.00001 Sale -$142K -2.35K -2.13% $60.40 108K Feb 16, 2024 Direct F1, F2
transaction ENVA Common Stock, par value $0.00001 Sale -$363K -6.04K -5.6% $60.00 102K Feb 20, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENVA Non-Qualified Stock Option (right to buy) with limited SAR Options Exercise -$188K -9K -7.88% $20.85 105K Feb 16, 2024 Common stock, par value $0.00001 per share 9K $59.95 Direct F3, F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.01 to $60.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 Includes timed-based restricted stock units previously granted to the Reporting Person.
F3 The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
F4 The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
F5 The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.52 to $60.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The options vested in substantially equal one-third increments on each of the following dates: February 13, 2019, February 13, 2020 and February 13, 2021.